Share on StockTwits

OHR Pharmaceutical (NASDAQ:OHRP) Director Thomas M. Riedhammer purchased 6,900 shares of OHR Pharmaceutical stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average cost of $7.39 per share, with a total value of $50,991.00. Following the purchase, the director now directly owns 124,667 shares of the company’s stock, valued at approximately $921,289. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of OHR Pharmaceutical (NASDAQ:OHRP) traded down 2.73% on Friday, hitting $9.63. 7,747,466 shares of the company’s stock traded hands. OHR Pharmaceutical has a one year low of $5.65 and a one year high of $20.00. The stock has a 50-day moving average of $8.67 and a 200-day moving average of $10.91. The company’s market cap is $227.4 million.

Separately, analysts at Brean Capital raised their price target on shares of OHR Pharmaceutical from $21.00 to $34.00 in a research note on Tuesday. They now have a “buy” rating on the stock.

Ohr Pharmaceutical Inc (NASDAQ:OHRP) is a biotechnology rollup company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.